Allen 2007 |
Allocation: not randomised (post‐hoc analysis of pooled data from 3 RCT's). |
Andrezina 2006 |
Allocation: randomised.
Participants: schizophrenia.
Interventions: sub‐population post‐hoc analysis of a previously reported RCT which has been included in this review. |
Argo 2004 |
Allocation: not randomised. |
Carson 2002 |
Allocation: not randomised. |
Carson 2004 |
Allocation: not randomised (naturalistic study). |
Casey 2002 |
Allocation: randomised.
Participants: schizophrenia or schizoaffective disorder.
Interventions: aripiprazole at different switching regimens as interventions ‐ no other comparator drug. |
Jung 2007 |
Allocation: not described.
Participants: schizophrenia.
Interventions: haloperidol with adjunctive aripiprazole compared with haloperidol with adjunctive placebo. |
Kelemen 2006 |
Allocation: not described.
Participants: schizophrenia.
Interventions: allocation to typical and atypical drugs ‐ no data available for individual drugs. |
Kim 2006 |
Allocation: quasi‐randomisation. |
Kim 2007 |
Allocation: randomisation.
Participants: schizophrenia or schizoaffective disorder.
Interventions: switch from existing antipsychotics to aripiprazole and other antipsychotics.
Aripiprazole not compared with any specific antipsychotic. |
Petrie 1997 |
Allocation: not randomised, review. |
Shim 2006 |
Allocation: not described.
Participants: schizophrenia, with hyperprolactinaemia after taking haloperidol.
Interventions: aripiprazole versus placebo as adjunctive treatment for people receiving haloperidol. |
Swanson 2006 |
Allocation: not randomised. |
Talbott 2007 |
Allocation: not randomised (post‐hoc analysis of pooled data from 3 RCT's). |
Wu 2005 |
Allocation: quasi‐randomisation. |
Xia 2005 |
Allocation: randomised.
Participants: schizophrenia.
Interventions: allocation to aripiprazole and chlorpromazine.
Outcomes: no usable data. |